Navigating the bleeding risk dilemma in patients with atrial fibrillation on therapy with direct-acting oral anticoagulants: Comparing the HAS-BLED vs. DOAC Score
-
Published:2024-07
Issue:
Volume:
Page:
-
ISSN:0953-6205
-
Container-title:European Journal of Internal Medicine
-
language:en
-
Short-container-title:European Journal of Internal Medicine
Author:
Soler-Espejo Eva,
Rivera-Caravaca José MiguelORCID
Reference21 articles.
1. The Impact of Polypharmacy on the Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation;Grymonprez;Thromb Haemost,2024
2. Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF registry phase II and III;Romiti;Thromb Haemost,2022
3. Atrial fibrillation: stroke prevention;Chao;Lancet Reg Health Eur,2024
4. Teppo K., Lip G.Y.H., Airaksinen K.E.J., Halminen O., Haukka J., Putaala J., et al. 2024. Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort. The Lancet Regional Health – Europe. https://doi.org/10.1016/j.lanepe.2024.100967.